Tango Therapeutics develops targeted cancer medicines that aim to kill tumor cells with specific genetic alterations. It last closed at $21.73 on Nov 20, down 4.32% on the day. The next earnings report for TNGX is expected around Thu, Mar 4, 2027. For the quarter ended Sep 2026, TNGX reported EPS of -$0.39 on revenue of $0, with revenue down 100.0% from a year ago. Over its last 8 reports the stock moved an average of 11.1% the session after earnings. Over the last 12 months TNGX insiders bought $0 of stock on the open market and sold $8.2M, according to SEC Form 4 filings.
AI Auto Pilots
Is TNGX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TNGX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on TNGXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
TNGX · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 6% below its 20 day and 8% below its 50 day average. It is 7% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 44). The nearest support is the swing low (Oct 30) at $21.71, and the nearest resistance the Pivot at $22.14.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 8.6%/day
Key levels
$34.3952 week high+58.3%
$24.97100 day average+14.9%
$23.49Swing high (Jun 1)+8.1%
$23.4550 day average+7.9%
$23.16200 day average+6.6%
$22.9420 day average+5.6%
$22.64Pivot R1+4.2%
$22.14Pivot+1.9%
$21.73Last close
$21.71Swing low (Oct 30)−0.1%
$21.22Pivot S1−2.3%
$8.3052 week low−61.8%
Indicators
RSI (14)
44.43
Middle of its range
Neutral
MACD
-0.21
Below its signal line
Bearish
Stochastic
24.2
Middle of its range
Neutral
ADX (14)
11.7
No clear trend
Williams %R
-82.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-69.3
Oversold below −100, overbought above 100
Neutral
Rate of change
+1.1%
Change over 10 sessions
Bullish
ATR (14)
$1.86
Typical daily range, 8.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 17.4%/day
Key levels
$34.3952 week high+58.3%
$24.97100 day average+14.9%
$23.49Swing high (Jun 1)+8.1%
$23.4550 day average+7.9%
$23.16200 day average+6.6%
$22.9420 day average+5.6%
$22.64Pivot R1+4.2%
$22.14Pivot+1.9%
$21.73Last close
$21.71Swing low (Oct 30)−0.1%
$21.22Pivot S1−2.3%
$8.3052 week low−61.8%
Indicators
RSI (14)
47.42
Middle of its range
Neutral
MACD
0.23
Below its signal line
Bearish
Stochastic
28.8
Middle of its range
Neutral
ADX (14)
32.8
Trending up
Williams %R
-86.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-66.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−8.6%
Change over 10 sessions
Bearish
ATR (14)
$3.79
Typical daily range, 17.4% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for TNGX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how TNGX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow TNGX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for TNGXHow many large options trades hit TNGX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in TNGX in the last 90 days.
From SEC Form 4 filings by TNGX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TNGX is in one of them and how their past TNGX trades turned out.
Tango Therapeutics is a biopharmaceutical company based in Boston, Massachusetts, that develops targeted cancer medicines. Its lead candidates are small molecule drugs designed to kill cancer cells that carry specific genetic changes while largely sparing normal cells. Its main programs target the PRMT5 protein in cancers with a specific gene deletion, including pancreatic and lung cancers and glioblastoma, a type of brain cancer. The company aims to treat patients whose tumors share these genetic features.